Yan Peng

Effectiveness of convalescent plasma therapy in severe COVID-19 patients

Kai Duan, Bende Liu, Cesheng Li et al. · Proceedings of the National Academy of Sciences · 2020 · 2K citations · Full text

Medicine, Hematology, Infectious Diseases +16

Atorvastatin and fluvastatin are associated with dose‐dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: Results from ERCHIVES

Tracey G. Simon, Hector Bonilla, Yan Peng et al. · Hepatology · 2016 · 178 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Direct-Acting Antiviral Therapy for HCV Infection Is Associated With a Reduced Risk of Cardiovascular Disease Events

Adeel A. Butt, Yan Peng, Ashfaq Shuaib et al. · Gastroenterology · 2018 · 160 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

The feasibility of convalescent plasma therapy in severe COVID- 19 patients: a pilot study

Kai Duan, Bende Liu, Cesheng Li et al. · medRxiv · 2020 · 129 citations · Full text

Medicine, Hematology, Infectious Diseases +17

SARS-CoV-2 Vaccine Effectiveness in a High-Risk National Population in a Real-World Setting

Adeel A. Butt, Saad B. Omer, Yan Peng et al. · Annals of Internal Medicine · 2021 · 129 citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +14